Teva Pharma (TEVA)

Company Ticker Sector | Industry Quality PAR
Teva Pharma TEVA Healthcare | Drugs (Specialty & Generic) 51 18.7%
Current Price (07/17) $7.83
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 17,942.0
Sales Growth Forecast 0.5%
Net Profit Margin 16.0%
Projected Shares Outstanding 1,116.67
EPS - Five year Forecast $2.64
Average P/E Ratio 7.0
Projected Average Price $18.47
Price Appreciation (Annualized) 18.7%
Annual Dividend Yield 0.0%
Projected Annual Return 18.7%
Quality
Financial Strength 72 17.9
EPS Stability 59 14.7
Industry Sales Growth Rate 9.5% 0.7
Industry Net Profit Margin 17.0% 11.8
Calculated Quality Rating 45.0
Fool CAPS

Total Players

2288 Outperforms
78 Underperforms
 

All-Stars (331)

323 Outperforms (98%)
8 Underperforms
 
Fundamental Data Updated: 07/12/2019

MIPAR 8.8%  
Sweet Spot 13.8% - 18.8%  

Top In Drugs (Specialty & Generic)

Ticker Quality PAR
SUPN 76 24.7%
TEVA 51 18.7%
MNK 22 18.3%
AGN 70 5.8%
TARO 47 11.2%

Top In Healthcare

Ticker Quality PAR
ALGN 99 21.4%
ABMD 82 19.1%
JAZZ 94 15.1%
CMD 92 14.1%
ABBV 87 15.4%